genomics

The latest group includes several firm developing genomics tools or diagnostics, but COVID-19 is preventing them from accessing their lab space for the time being.

The funding comes about three years after Amgen provided the school with $1.5 million for a master's degree program in human genetics and genetic counseling.

The program, launched last year, is designed to help early-career investigators who have primarily worked within groups pursuing independent research.

Investigators saw signs that risky TP53 missense mutations may interfere with wild type copies of the tumor suppressor gene in acute myeloid leukemia and other myeloid cancers.

Vertex Pharmaceuticals has invested £10.5 million in the British analytics company as the companies launch a multiyear R&D partnership seeking novel drug targets.

The grants are designed to help investigators working within groups pursue independent research and advance their careers in genomic science.

Researchers at the annual Association of Biomolecular Resource Facilities meeting said they are joining single-cell sequencing to other single-cell analyses.

The partners plan to share information about joint R&D activities and establish research facilities and laboratory infrastructure in Ethiopia.

The bill aims to reduce barriers to the use of genetic and genomic testing, including for children on Medicaid with a suspected genetic disease.